Leandro Jimenez
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
- Oncology 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- André N. A. Gonçalves (2 shared papers)Helder Imoto Nakaya (2 shared papers)Rachel L. Creighton (1 shared paper)Antônio Edson Rocha Oliveira (1 shared paper)Rodrigo L.T. Ogava (1 shared paper)Jean Pierre Schatzmann Peron (1 shared paper)Bruna Garbes Gonçalves Pinto (1 shared paper)Youvika Singh (1 shared paper)
- Journals
- Oncotarget (1 paper)Frontiers in Medicine (1 paper)The FASEB Journal (1 paper)Toxicological Sciences (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- BrazilUnited StatesSpain
In The Last Decade
Leandro Jimenez
9 papers receiving 726 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 263
- Oncology 168
- Cancer Research 57
- Cell Biology 41
- Hepatology 17
Countries citing papers authored by Leandro Jimenez
This map shows the geographic impact of Leandro Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leandro Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leandro Jimenez more than expected).
Fields of papers citing papers by Leandro Jimenez
This network shows the impact of papers produced by Leandro Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leandro Jimenez. The network helps show where Leandro Jimenez may publish in the future.
Co-authors
The 25 scholars most cited alongside Leandro Jimenez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 316 | |
| 2 | 2015 | 189 | |
| 3 | 2019 | 111 | |
| 4 | 2019 | 30 | |
| 5 | 2021 | 29 | |
| 6 | 2017 | 22 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 13 | |
| 9 | 2019 | 5 |
About Leandro Jimenez
Leandro Jimenez is a scholar working on Infectious Diseases, Oncology, Hepatology, Cancer Research and Cell Biology, having authored 9 papers that have together received 736 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Folate and B Vitamins Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Infectious Diseases (263 citations), Oncology (168 citations), Cancer Research (57 citations), Cell Biology (41 citations) and Hepatology (17 citations). Leandro Jimenez has collaborated with scholars based in Brazil, United States and Spain. Frequent co-authors include André N. A. Gonçalves, Helder Imoto Nakaya, Rachel L. Creighton, Antônio Edson Rocha Oliveira, Rodrigo L.T. Ogava, Jean Pierre Schatzmann Peron, Bruna Garbes Gonçalves Pinto, Youvika Singh, Anamaria A. Camargo and Luiz F. L. Reis. Their work appears in journals such as Oncotarget, Frontiers in Medicine, The FASEB Journal, Toxicological Sciences and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.